BURT ROSEN STRATEGIES

Client	Reported $	Filings	Share
ACCURAY	$200.0K	19	55.6%
ATEA PHARMACEUTICALS	$160.0K	18	44.4%

Issue	Activities	Share
`HCR` Health Issues	6	66.7%
`TAR` Tariff (miscellaneous tariff bills)	3	33.3%

Entity	Contacts	Share	Type
HOUSE OF REPRESENTATIVES	3	33.3%	Congress
Health & Human Services, Dept of (HHS)	3	33.3%	Agency
SENATE	3	33.3%	Congress

1 of 1 lobbyist (100%) listed a prior covered government position on a lobbying filing.

BURT ROSEN: President

Posted	Period	Client	Type	Income	Expenses	Activities	Lobbyists
2023-05-04	2023 Q1	ATEA PHARMACEUTICALS	`1st Quarter - Report`	—	—	1	1
2023-05-04	2023 Q1	ACCURAY	`1st Quarter - Report`	—	—	1	1
2023-02-06	2022 Q4	ATEA PHARMACEUTICALS	`4th Quarter - Report`	—	—	1	1
2023-02-06	2022 Q4	ACCURAY	`4th Quarter - Report`	—	—	1	1
2022-11-02	2022 Q3	ATEA PHARMACEUTICALS	`3rd Quarter - Report`	$10.0K	—	1	1
2022-11-02	2022 Q3	ACCURAY	`3rd Quarter - Report`	$10.0K	—	1	1
2022-08-08	2022 Q2	ATEA PHARMACEUTICALS	`2nd Quarter - Report`	$10.0K	—	1	1
2022-08-08	2022 Q2	ACCURAY	`2nd Quarter - Report`	$10.0K	—	1	1
2022-05-09	2022 Q1	ATEA PHARMACEUTICALS	`1st Quarter - Report`	$10.0K	—	1	1
2022-05-09	2022 Q1	ACCURAY	`1st Quarter - Report`	$10.0K	—	1	1

BURT ROSEN · prior govt

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.

Income & Lobbyist Activity Last 10 years, by quarter

Clients who have hired BURT ROSEN STRATEGIES in the past (2) · ranked by reported income and expenses

Issues lobbied 2023 Q3 – 2024 Q2, the firm's latest quarters on file

Government entities contacted 2023 Q3 – 2024 Q2, the firm's latest quarters on file

Revolving door lobbyists who have worked for the firm

Political contributions semiannual LD-203 reports by the firm and its lobbyists

Filings 37 total

Lobbyists who have worked for the firm (1)